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Abstract
Noroviruses are the most common cause of viral gastroenteritis. An increase in the number of globally reported norovirus
outbreaks was seen the past decade, especially for outbreaks caused by successive genogroup II genotype 4 (GII.4) variants.
Whether this observed increase was due to an upswing in the number of infections, or to a surveillance artifact caused by
heightened awareness and concomitant improved reporting, remained unclear. Therefore, we set out to study the
population structure and changes thereof of GII.4 strains detected through systematic outbreak surveillance since the early
1990s. We collected 1383 partial polymerase and 194 full capsid GII.4 sequences. A Bayesian MCMC coalescent analysis
revealed an increase in the number of GII.4 infections during the last decade. The GII.4 strains included in our analyses
evolved at a rate of 4.3–9.061023 mutations per site per year, and share a most recent common ancestor in the early 1980s.
Determinants of adaptation in the capsid protein were studied using different maximum likelihood approaches to identify
sites subject to diversifying or directional selection and sites that co-evolved. While a number of the computationally
determined adaptively evolving sites were on the surface of the capsid and possible subject to immune selection, we also
detected sites that were subject to constrained or compensatory evolution due to secondary RNA structures, relevant in
virus-replication. We highlight codons that may prove useful in identifying emerging novel variants, and, using these,
indicate that the novel 2008 variant is more likely to cause a future epidemic than the 2007 variant. While norovirus
infections are generally mild and self-limiting, more severe outcomes of infection frequently occur in elderly and
immunocompromized people, and no treatment is available. The observed pattern of continually emerging novel variants
of GII.4, causing elevated numbers of infections, is therefore a cause for concern.
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Introduction
Noroviruses (NoV) are the most common cause of acute viral
gastroenteritis [1,2], with the numbers of reported outbreaks
peaking characteristically between November and March in the
northern hemisphere [3]. Illness is usually self-limiting and
symptoms, comprising acute onset vomiting and watery diarrhea,
subside within one to three days [4]. The relevance of studying
NoV lies in their high prevalence in the population [5], and in the
more severe and prolonged illness that is seen among elderly and
immunosuppressed patients [6–8]. NoVs are highly infectious, due
to the combination of an extremely low infectious dose (an
estimated ID50 of less than 20 viral particles [9]), very high levels
of shedding (around 108 but up to .1010 RNA copies per gram of
stool) and prolonged shedding after clinical recovery [10,11]. NoV
outbreaks, which may affect hundreds of people and are
notoriously difficult to control, are primarily associated with
places where people are in close contact, for example hospitals and
long-term care facilities.
NoVs are a genetically diverse group of positive sense single-
stranded RNA viruses from the Caliciviridae family. Their 7.5 kb
genome includes three open reading frames (ORFs). The first
ORF encodes a polyprotein that is post-translationally processed
to form the non-structural proteins, the second and third ORFs
encode the major and minor structural proteins; VP1 or the capsid
protein and VP2. The viral capsid is formed by 180 copies of the
major capsid protein, and governs antigenicity, host-specificity and
environmental stability.
NoVs are classified into five distinct genogroups, which are
further subdivided into genotypes, based on their amino acid capsid
sequence. Molecular epidemiological studies have shown that in
recent years approximately 70% of NoV outbreaks among
humans have been caused by one dominant genotype, GII.4
[12–17].
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With continuous surveillance systems in place in some countries
since the mid-1990s, it has become apparent that the number of
reported NoV outbreaks, and especially those caused by GII.4 strains
has risen since the appearance of the 2002 variant of GII.4
[12,15,18–21]. Since then, genetically distinct GII.4 variants have
emerged, and spread rapidly across the world causing epidemic waves
of NoV illness [20,22]. To date, three variants named after the year
when they were first detected have been identified in populations
across the world (the 2002, 2004 and 2006b variants [22]). The
emergence of each of these three variants was followed by ‘hot’ NoV
winters with sharply increased numbers of reported outbreaks. Older
strains belonging to the lineage designated 1996 were also detected
around the world, although surveillance was limited at that time.
The pattern of continuous lineage turnover, referred to as
epochal evolution [23], with emerging new variants replacing
previously predominant circulating ones, is strongly reminiscent of
what is observed in the molecular epidemiology of Influenza A
virus (IAV). The evolutionary interaction between IAV and the
human immune response results in antigenic drift, illustrated by
the characteristic ladder-like tree shapes for hemagglutinin and
neuraminidase surface proteins [24]. Long-term partial immunity
to the virus induces sharp fitness differences among strains and
drives rapid amino acid replacement at key antigenic sites,
pinpointed by in vitro and in silico analyses [25,26]. Whereas
antigenic data can be readily generated for IAV, allowing the
comparative mapping of antigenic and genetic evolution [27],
research of NoV antigenic properties has been hampered by the
lack of a simple cell culture model [28]. However, recent
publications indicate that the genetic differences between NoV
genotypes, and also between variants of the GII.4 genotype,
translate into distinct antigenic types, although molecular
determinants remain largely unclear [23,29]. Thus, individuals
may be repeatedly infected by strains belonging to different
genotypes, and also, because immunity against NoV infection is
short-lived at best [30–32], possibly repeatedly by strains of the
same genotype. As a result, the impact of immune responses on
NoV epidemiology remains poorly understood and phylodynamic
and molecular adaptation studies may provide some key insights.
In this study, we aimed to provide a rigorous measurement of
NoV GII.4 diversity through time, and we investigated viral
population expansions in relationship to the increased numbers of
infections reported in recent years. Evolutionary and population
dynamics of GII.4 NoVs were estimated by a Bayesian coalescent
approach, using two different datasets of sequences from strains
with known detection dates, between 1987 and 2008. One set of
sequences contained full capsid sequences, the other short partial
polymerase sequences, which had been obtained for standard-
procedure genotyping in NoV surveillance in Europe [13] (http://
www.noronet.nl/fbve/) and from the global NoV surveillance
network Noronet [22] (http://www.noronet.nl/).
We also tested whether these dynamics differed from neutral
expectations, so whether and how they were shaped by selective
pressure, and we attempted to further elucidate the molecular
determinants of NoV evolutionary and epidemiological dynamics
using in silico techniques. To identify the molecular characteristics
of NoV GII.4 strain replacement, we investigated both directional
and diversifying selection and elucidated capsid protein positions
showing evidence for co-evolutionary dynamics acting between
sites.
Results
Recombination analysis
To examine the extent to which recombination has shaped NoV
evolution, we analyzed an alignment of 20 GII.4 sequences, two
for each variant, spanning the genome from region A (a gene
region in ORF1 that is commonly used for genotyping purposes,
see Materials and Methods, and [22] and [33]) up to the 39end of
the capsid. Using GARD (Genetic Algorithm for Recombination
Detection), VisRD (Visual Recombination Detection) and RDP3
(Recombination detection program), significant phylogenetic
variability was identified in this genome region, which could be
attributed to a recombination event for the 2003Asia variant, a
GII.4 variant previously identified as a recombinant lineage,
mainly detected in Asia, and rarely in Europe, Oceania or the
Americas [22]. The crossover point lay in the ORF1/2 overlap, a
position previously identified as a recombination hotspot in NoV
[34,35]. Further analyses below were based on polymerase and
capsid gene sequences that do not include this breakpoint, and no
recombination could be detected in those individual data sets using
the Phi test [36].
Time-measured phylodynamic analyses
To test whether GII.4 evolution deviated from selective
neutrality, we applied a genealogical neutrality test that involved
Bayesian coalescent inference, a tree-based summary statistic (DF),
and posterior predictive simulation [37]. Using a constant
population size demographic prior, the capsid data set (194
sequences, 1623 nt) showed significantly more negative DF than
expected (P,0.01), suggesting a selective process that generated a
significant excess of mutations on terminal branches. The same
was true using an exponential growth prior, but a Bayes factor test
did not support an exponential growth scenario (ln BF constant
versus exponential growth =22.47). A Bayes factor comparison
also favored a constant population size model over an exponential
growth model for the matched polymerase data set (172 sequences,
247 nt)(ln BF =22.23). In this case, we did not observe a
significant difference in DF (P = 0.15). Because the polymerase
sequences were considerably shorter, they provided less informa-
tion to evaluate branch length properties. To counteract the loss of
power we increased the number of sequences, and indeed, an
analysis of the complete polymerase sequences dataset (1383
Author Summary
Noroviruses, known as the viruses that cause the ‘stomach
flu’ or as the ‘cruise ship virus’, cause sporadic cases and
large outbreaks of gastrointestinal illness in humans. An
increase in norovirus outbreaks was reported globally
around 2002. Doubts remained as to whether this increase
was real, or caused by improved detection-techniques and
increased awareness. This study was performed to address
this ambiguity, and to determine the possible virological
causes for such changes. Using a population genetic
approach, we studied sequences of epidemic norovirus
strains collected through time and we indeed demonstrat-
ed expanding epidemic dynamics. Global epidemics were
caused by subsequent variants of norovirus, observed in
2002, 2004 and 2006 and at a smaller scale in 1996,
whereas no evidence for such epidemic evolutionary
patterns occurring previous to these peaks. Based on the
sequences analyzed the strains of the genotype under
study here were shown to have circulated at least since the
early 1980s, and likely earlier. We showed that not only
surface exposed sites on the outside of the virus shell were
under selective pressure, involved in avoiding host
immune responses, but also codons that are apparently
conserved for the purpose of virus replication.
The Evolutionary Dynamics of Epidemic NoV Strains
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sequences, 247 nt) rejected the model of neutral evolution
(P = 0.001). As previously introduced [37], this neutrality test
relies on relative restricted demographic models governed by a
limited number of parameters to capture large-scale demographic
trends. To investigate the sensitivity to demographic detail, we
extended the posterior predictive simulation procedure to
accommodate highly parametric demographic models, which
result in a more complex picture of norovirus dynamics (see
below). Using a Bayesian skyline plot (BSP) model as demographic
function [38], similar conclusions could be drawn from the
neutrality test: significantly more negative DF values than expected
under neutrality were observed for the capsid data set (P = 0.019)
and the complete polymerase data set (P = 0.018), whereas the
matched polymerase lacked power in rejecting neutrality
(P = 0.029).
The demographic inference using the BSP model is summarized
in Figures 1A and 1B, which essentially plot Net as a function of
time. Ne t can be considered a measure of relative genetic diversity
that, in turn, reflects the number of effective infections established
by the virus (see also the Materials and Methods section).
Figure 1. Phylodynamics of the GII.4 noroviruses. The left panel (A, B, C) describes analysis of the polymerase dataset, the right panel (D, E, F)
the analysis of the capsid dataset. A) Bayesian Skyline Plot (BSP) of GII.4 NoV partial polymerase sequences, representing the relative genetic diversity,
a measure for the number of effective infections, of circulating GII.4 NoVs through time. The black line represents the median posterior value, the
grey lines the 95% Highest Probability Density (HPD) intervals. The Y-axis depicts the value of Net on a logarithmic scale. B and E) Surveillance data of
NoV GII.4 strains, detected in outbreaks, included for comparison. Only European surveillance data was obtained from the FBVE database and from
Dutch surveillance [12,13]. The different GII.4 variants detected in the outbreaks are represented by different colors, showing the displacement of
subsequent variants through time. The same colors were used in panels D and F, the color legend is shown under panel F. C) Maximum Clade
Credibility (MCC) Tree of NoV GII.4 partial polymerase dataset. The MCC tree represents an estimate of the posterior distribution of tree topologies
and branch lengths. Different variants are represented in different colors, the tree is scaled in units of time with tips constrained to strain detection
dates. D) BSP of the GII.4 NoV capsid dataset. F) MCC tree of the GII.4 NoV capsid dataset.
doi:10.1371/journal.ppat.1000884.g001
The Evolutionary Dynamics of Epidemic NoV Strains
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Uncertainty in the estimated parameters was evaluated using 95%
Highest Probability Density (HPD) intervals. The Maximum
Clade Credibility (MCC) trees from the same Bayesian analyses
(Figures 1C, D) summarize the NoV evolutionary histories, and
the stepwise emergence of the subsequent variants on a time scale.
For comparison, surveillance data of reported NoV outbreaks with
confirmed GII.4 variant type were imposed on the BSPs.
The changing patterns of NoV genetic diversity generally
revealed seasonal dynamics, albeit with markedly varying
resolution among the two datasets. The BSP for the polymerase
dataset (Figure 1A) showed peaks for Net that coincided with the
epidemic peaks observed in norovirus surveillance systems in the
northern hemisphere winters 2002–03, 2004–05 and 2006–07.
The BSP obtained from the capsid dataset (Figure 1B) showed a
pattern that was more difficult to reconcile with epidemiological
observations. Values for Net were highest in the years 1997–1999,
and the emergence of the 2002 variant, which had a strong impact
in the population according to surveillance data, did not coincide
with a pronounced upsurge in the BSP. Comparison of the BSPs
obtained for both genes, illustrated that unraveling seasonal
population dynamics with associated population bottlenecks for
viruses like NoV, may require a sufficiently high sampling density.
In fact, reducing the partial polymerase dataset to a similar
number of sequences drastically diminished the resolution of the
BSP analysis (Figure S1). In particular the 2004–05 and 2006–07
epidemics were not well reflected in the BSP derived from this sub-
set of polymerase sequences that matched the capsid dataset in
size, both genetically and temporally. The 2002–03 epidemic,
following the replacement of the 1996 variant by the 2002 variant,
wa´s however clearly noticeable in the matched polymerase set,
whereas it was not in the capsid data set. Considering the
associated MCC trees (Figures 1C, 1D), it is conceivable that
following the relatively long build-up of genetic variation during
the circulation of the 1996-variant, its replacement by the 2002
variant signified a massive and sudden loss of diversity; a
population bottleneck. The 2002 variant split into two distinct
subclusters for the polymerase dataset. These lineages arose almost
immediately after the emergence of the 2002 variant, and
individually coalesced to a Most Recent Common Ancestor
(MRCA) shortly before their diversification. The capsid 2002
variant cluster also grouped in two sublineages, but they coalesced
more gradually to their MRCA.
Comparison of the variant dynamics in the MCC trees to their
respective BSPs suggested that variant replacement was not always
absolute across subsequent epidemic seasons. To investigate this in
more detail, we performed the coalescent analyses on partial
polymerase datasets for the individual major GII.4 variants
separately (Figure 2). Whereas the pattern of rapid emergence,
followed by an (epidemic) peak and later peaks of diminishing size
observed for the 2002, 2004 and 2006a variants were very similar,
the patterns obtained for 1996 and 2006b were quite different.
The 1996 variant, that was detected in the population during a
relatively long period, but at low reporting frequencies after the
initial epidemic (winter of 1995–1996, in the northern hemisphere)
(Figure 1A/B), showed an increasing trend in the Net values
persisting long after this first peak. The 2006b strain showed a less
defined pattern, with multiple, smaller peaks.
The demographic component is part of a full Bayesian model
that enables the inference of time-scaled evolutionary histories and
rates of molecular evolution from temporally-spaced sequence
data. Rates of nucleotide substitution and the MRCA’s of the
included GII.4 sequences were listed in Table 1. The substitution
rates found for the less densely sampled datasets, namely the
complete capsid sequences (5.3361023 substitutions per site per
year) and the matched polymerases set (4.3261023 substitutions
per site per year) are lower than the rate found for the large partial
polymerase dataset (8.9861023 substitutions per site per year).
The estimated MRCA for these GII.4 strains lies in the first half of
the 1980s (Table 1).
Molecular adaptation
Because the genealogical test rejected selective neutrality for the
capsid gene, we attempted to identify the molecular determinants
of this selective process through two different approaches that were
not previously applied on NoV data, namely DEPS [38] and co-
Figure 2. Bayesian Skyline Plots of different GII.4 variants
analyzed separately. Only the mean population sizes through time
were plotted for clarity.
doi:10.1371/journal.ppat.1000884.g002
Table 1. Evolutionary parameters inferred by Bayesian analysis.
Dataset (number seqs, length of seq) Median MRCA (HPD) Median Rate (61023) Subst/site/year (HPD)
GII.4 Capsids July ’82 (Oct ’77–May ’86) 5.33 (4.62–6.02)
N= 194, length = 1623nt
GII.4 Polymerases Oct ’85 (Sept ’82–Jun ’87) 8.98 (7.73–10.4)
N = 1383, length = 247 nt
GII.4 Polymerases matched to capsids Jun ’85 (Jun ’79–Mar ’88) 4.32 (3.50–5.20)
N = 172, length = 241 nt
doi:10.1371/journal.ppat.1000884.t001
The Evolutionary Dynamics of Epidemic NoV Strains
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evolutionary analysis of amino acids [39], and complemented this
with novel extensions of previously performed codon substitution
model analyses [23,40]. The partial polymerase sequences under
analysis in this study are very short and have therefore not been
included in these analyses.
Codon substitution model
In order to apply a codon model based on a general bivariate
discrete distribution (GBDD) of dN and dS [41], we employed a
small sample AIC, which suggested that six rate classes (D = 6)
provided the best fit to the capsid data. The proportion of sites
within these classes and corresponding dN and dS estimates are
represented by Figure 3A and 3B. The model included one rate
class describing positive selection (dN ( = 0.77).dS ( = 0.00)), with
an estimated 0.93% of sites occupying this class. An empirical
Bayes approach identified sites 6, 9, 15, 47 and 534 (0.93%) to be
under diversifying positive selection (Table 2). Three of the sites (6,
9 and 534) were confirmed by a site-by-site Fixed Effects
Likelihood (FEL) analysis at p,0.05, while the remaining two
(15 and 47) were borderline significant (p = 0.06 and p = 0.10). The
rates of false positives for FEL analyses at p = 0.05 was
approximately 0.04 and 0.08 at p = 0.1, based on dataset-matched
neutral simulations, suggesting that the putatively selected sites
were not due to elevated rates of false positives at given nominal
significance values.
To uncover population level selection processes, FEL analysis
may be more appropriately applied to internal branches (iFEL)
[42]. That this approach suited our data was also suggested by our
genealogical tests, which identified an excess of slightly deleterious
mutations on terminal branches, indicative of within host
evolution. The use of iFEL enabled us to avoid this effect and
revealed 8 codons under positive selection at the population level
including 6, 9, 47, 352, 372, 395, 407, 534, with p#0.05.
Directional selection model
Codon models are powerful tools to detect an unusually high
rate of nonsynonymous replacement, which generally occurs
under a scenario of diversifying selection. However selection of
episodic nature, e.g. directional selection or frequency-dependent
selection is more difficult to detect and involves the question of
which residues are being selected for or against [38]. A directional
evolution in protein sequences analysis (DEPS) of NoV capsid
sequences revealed elevated substitution rates towards 4 residues:
V, S, A, T. Four sites were identified to be involved in this
directional evolution; amino acids 9 (with inferred amino acid
substitution pattern: NRT/SRN), 294 ((VR)ARS/PRART ),
333 (LRM/V/LRMRV), and 395 (-RTRA) (Figure S2).
Epistatic effects, or co-evolutionary analyses of amino
acids
In folded proteins amino acids are not arranged linearly; many
functionally interact, making their evolution dependant on that of
others. Various types of interactions exist, and interacting sites are
not necessarily direct neighbors in either the protein sequence or in
the 3D protein structure. We used Bayesian graphical models
(BGM) to detect co-evolving sites. The sites identified, are shown as
a network in Figure 4, and sites for which co-evolution was detected
but seemed less supported are shown in Figures S3A and S3B. Two
values for the posterior probabilities are given, obtained from the
analyses allowing for either one or two co-dependencies. Sites 231
and 209, and 238 and 504, which co-evolved as two coupled sets
(Figures S3A and S3B), were not involved in recent variant
transitions. Therefore we conclude that they were not under
selective pressure that governed variant replacement dynamics.
All sites for which molecular adaptation was detected are listed
presented in Table 3. We marked relevant sites located on top of
the capsid dimer in Figure 5.
Figure 3. Codon substitution rate classes of GII.4 capsids. A) Inferred weights for each evolutionary rate class, showing the relative proportion
of sites belonging to the given classes. The diagonal line divides the regimes of positive selection (dN/dS.1, above) and negative selection (dN/
dS,1, below). B) Approximate inferred posterior distribution of synonymous (alpha) and non-synonymous (beta) substitution rates, showing the
variance of each rate estimate. Color intensity is proportional to the square root of the density, and solid oval plots delineate approximate 95%
confidence sets.
doi:10.1371/journal.ppat.1000884.g003
The Evolutionary Dynamics of Epidemic NoV Strains
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RNA secondary structure predictions
Our study identified codon 6 to be under positive, diversifying
selection and codon 9 to be under diversifying as well as
directional selection; others performing dN/dS analyses detected
positive selection at these sites as well [23,40]. The variation in
codon 6 is due to AAT (Asn) to AGT (Ser) changes. The signal for
codon 9 is solely attributable to substitutions at the second codon
position of this site; AAC (Asn), ACC (Thr) and AGC (Ser). The
N-terminal region of ORF2 was otherwise highly conserved.
Because contrary to the other amino acids that were identified to
be under selective pressure, the part of the protein encoded by
these two amino acids is located on the inside of the virus capsid
structure, and not surface exposed, we investigated the potential
RNA secondary structure encoded by this region. In silico
replacement of nucleotides at position 17 (codon 6) did not lead
to secondary structure changes (not shown). Secondary structure
predictions of the RNA encoding the 59end of ORF2 were
performed with all four possible nucleotides modeled at position
26 (Figure 6). The 4 nucleotides upstream of the ATG, generally
thought to form the boundary of the subgenomic RNA [43] were
included in the predictions. The presence of A, C, or G generated
similar structures, when however a T (U) was modeled, extra
pairing possibilities arose, lengthening the stem of the first stem-
loop structure, and thus shortening the stretch of free nucleotides,
available for ribosome binding, from 11 to 9.
Discussion
Following the emergence of the genetically and antigenically
novel GII.4 2002 variant in 2002, a sharp rise in the number of
reported NoV outbreaks was recorded in several surveillance
systems throughout the world [15,18,21]. Earlier, in 1995–96, a
similar rise had been reported resulting from the emergence of
another cluster of GII.4 - the 1996 variant [44]. The 1996 and
2002 variants have by now been succeeded by successive, highly
prevalent GII.4 variants. Some uncertainty remained, however, as
to whether the increase in the number of reported outbreaks was
the result of a true rise in the numbers of infections, or of improved
detection techniques combined with better reporting due to
heightened awareness. In order to resolve this ambiguity in NoV
epidemic history we applied Bayesian statistical phylodynamic
techniques (Bayesian Skyline Plots, or BSPs) to alignments of a
large number of GII.4 sequences. We showed that these
techniques confirm the epidemic behavior of the GII.4 variants
Table 2. Codons under selection, identified by site-by-site
FEL analysis.
Codon Empirical Bayes Factor FEL p-value Substitution Pattern
6 125 0.01 0 syn
6 non-syn (N:S)
9 3125 0.007 0 syn
9 non-syn (N:S/T)
15 177 0.06 0 syn
7 non-syn (A:T)
47 37 0.10 0 syn
6 non-syn (I:V)
534 761 0.04 0 syn
9 non-syn (A:T/V)
doi:10.1371/journal.ppat.1000884.t002
Figure 4. Sites identified by Bayesian graphical models to co-
evolve. Amino acid sites 297, 372, 368, 394, 407, 534 and 540 of the
GII.4 capsid protein were depicted as trees showing different amino
acids in different colors. Each connection is associated with posterior
probabilities (P) for single (above or left) or two (below or right)
dependencies.
doi:10.1371/journal.ppat.1000884.g004
The Evolutionary Dynamics of Epidemic NoV Strains
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during the past decade, and that the increase in the number of
NoV infections suggested from global surveillance data coincides
with the rise of the GII.4 variant. Additionally we applied in silico
techniques to identify sites under various types of selective pressure
and to unravel epistatic interactions in the capsid protein.
BSP reveals most recent epidemics, but no additional
ones
The first rise in the BSP estimates of Net (a measure of effective
population size) in the polymerase dataset was seen just before
January 1996, around the time the first global GII.4 epidemic was
noted [45] (Figure 1). Interestingly, rather than appearing as a
defined epidemic peak lasting one winter season, Net increased
continuously through January 2000. Surveillance data from
around the world identified relatively few GII.4 outbreaks among
NoV positive outbreaks in the period between 1997 and spring
2002 [12,22]; instead, a relatively high diversity of other, non-
GII.4 genotypes was detected in this period. The high Net
observed for this period is congruent with the long branch-lengths
in the MCC tree during this period. Given the prolonged
circulation time of the 1996 variant compared to the later
variants, it seems likely that the BSP in this instance is a better
representative of the relatively high genetic diversity built up in an
extended period of co-circulation of the 1996 variant with other
genotypes, rather than of the number of infections with this
particular variant. The three most recent GII.4 epidemics caused
by emerging GII.4 variants were clearly visible in the polymerase
BSP. The 2002 epidemic was preceded by a sharp decline in Net,
indicative of a purifying selection event against the previously
dominating variant, in which the diversity that had been gradually
built up by the long circulation of the 1996 variant collapsed.
Next, coinciding with the off-seasonal peak observed in public
health surveillance systems in the northern hemisphere, Net in the
BSP rose sharply. After a brief and insignificant decline another
peak occurred in the winter season of 2002–03. During the
epidemic caused by the 2004 variant Net peaked slightly less high
and less long than during the 2002 epidemic peak. During the
2006–07 epidemic, with two distinct GII.4 variants circulating,
Net was the highest (Figure 2), and after this winter Net values
stayed high, corresponding with continued circulation of the
2006b variant, as also observed in surveillance.
Altogether, from the first half of the 1990s to present time, two major
changes were observed. First, epidemic waves have arisen that could
not be detected in earlier times, and second, the number of infections
has gone up. The baseline before 1996 corresponds to the trough levels
in between contemporary epidemics. Hence, the increased amount of
GII.4 outbreaks observed in outbreak surveillance seems to reflect an
actual increase of GII.4 infections in the population.
These conclusions are undoubtedly impacted by the comparatively
few available sequences from earlier years, which are, unfortunately,
not widely available, and as shown by the recent publication by Bok
et al., not easily attainable [40]. A search in archival stool samples
revealed that during the years 1974–1981 and 1987–1991 GII.4 was
not the most prevalent NoV genotype in hospitalized children with
gastroenteritis, but GII.3 was. Our sampling, albeit at lower frequency
during this period, would probably have detected possible unidentified
epidemic surges had they occurred. Altogether, although surveillance
data and demographic estimates are very different types of information,
their dynamics match remarkably well. The surveillance data is
presented on a linear scale and reflects the reported outbreaks of NoV-
gastroenteritis, which is probably an incomplete description of NoV
circulation, as many cases of NoV illness remain unreported. The BSPs
are presented on a log-scale, which makes for less sharp peaks than the
peaks observed in the surveillance data graphs.
Different GII.4 variants reached similar levels of genetic
diversity
The analysis of each major GII.4 variant separately (Figure 2)
indicated that Net values, a measure for relative genetic diversity,
Figure 5. Sites identified by molecular adaptation analyses
located on top of the GII.4 capsid dimer. Two parts of the dimer
were given different shades of blue, the sites identified as under
positive selection, co-evolving with other sites, or sites previously
identified to be involved in host-interactions, were colored yellow.
Ligands (B trisaccaride) bound in the binding pocket are shown in red.
Protein structure 2OBT was used for generating this representation [53].
doi:10.1371/journal.ppat.1000884.g005
Table 3. Molecular adaptation in the capsid protein, detected
by different maximum likelihood approaches.
REL FEL iFEL DIR Co-Ev
6 x x x
9 x x x x
15 x
47 x x
231 x (509)
238 x (504)
294 x
297 x (372)
333 x
352 x
368 x (372, 394)
372 x x (297, 368)
394 x (368, 407, 534)
395 x x
407 x x (394)
504 x (238)
509 x (231)
534 x x x x (394, 540)
540 x (534)
doi:10.1371/journal.ppat.1000884.t003
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and a proxy for the number of effective infections, of each variant
reached approximately similar proportions. The 2002, 2004 and
2006a variants each had one epidemic season, but the turnover
was relatively slow compared to e.g. influenza [46], resulting in
repeated seasons (of decreasing magnitude) of illness caused by the
same variant. For example, one main peak for Net was observed
for the 2004 variant during the 2004–05 winter, but a smaller peak
followed during the 2005–06 winter. This slow turnover may very
well have been caused by the fact that only incomplete immunity is
mounted against NoV after infection or alternatively that the pool
of susceptibles is not depleted within one season. Different BSPs
were obtained for GII.4 variants 1996 and 2006b, that persisted
longer than one season. Interestingly Net for the 1996 variant
increased just before the emergence of the 2002 variant. The
2006b variant showed no defined epidemic peak, but a series of
smaller peaks that did not coincide with annual winter-peaks. Two
sublineages of the 2006b variant, distinguishable by up to 5 amino
acid differences in the full capsid sequence [47] circulated in the
population. Of these only S368G has been recognized as a
polymorphism relevant for antigenic properties. Interestingly,
while only two 2006b strains with this mutation are present in our
capsid dataset, later full capsid sequencing revealed more strains of
this sublineage, and the polymerase dataset included more
sequences from this cluster. Thus, the 2006b variant may have
persisted in the population by changing its antigenic properties.
High sampling density is necessary for accurate estimate
of the effective population size of cyclic pathogen
While Bayesian coalescent analyses of the large partial
polymerase dataset reflected seasonal epidemic dynamics, the
analysis of the longer capsid sequences offered little detail about
the phylodynamic patterns of NoV. To investigate the nature of
this difference, we performed an analysis of polymerase sequences
matching the capsid sequences genotypically as well as temporally,
which showed that a lack of phylodynamic detail can generally be
attributed to a lower sampling density (supplemental materials,
Figure S1). This may not be so surprising as it was previously
thought that coalescent analyses would not be so effective at
capturing cyclical population dynamics [48]. Only recently, a
comprehensive analysis of a large H3N2 influenza virus dataset
(1302 taxa) was able to uncover seasonal dynamics from genetic
data [46]. Interestingly, this data set was similar in size compared
to the large dataset of partial NoV polymerases (1383 taxa)
presented here, although in the influenza study full gene segments
were analyzed. The population bottlenecks in the NoV GII.4
population history are to a large extent comparable to those seen
for influenza and constitute repetitive large scale losses of genetic
diversity. We note that viruses with seasonal dynamics do not
necessarily have to exhibit such dynamics in genetic diversity.
Short infections with strong cross-immunity, as seen for measles
virus, allow many strains to co-circulate with frequencies
contingent on neutral epidemiological processes [24]. For such
viruses, seasonal epidemics may arise from repeated exhaustion of
susceptible host populations [49]. Therefore, our phylodynamic
analysis predicts that there may only be partial subsequent cross-
immunity against GII.4 variants. It is important to note that
sampling size impacts the resolution of phylodynamic inference,
but the actual sampling scheme does not dictate a pattern of
fluctuating population size. Rambaut et al. [46] performed
simulations using various demographic scenarios but with a
sampling scheme used to obtain influenza genetic data from
seasonal epidemics. In all cases, the simulated demographic history
was accurately recovered. A sparse sampling prior to 2000 also
makes it difficult to unequivocally conclude an increase in GII.4
infections. However, we note that the value for Net before the first
documented epidemic resulting of the emergence of a new genetic
variant (the 1996-variant) in the BSP is lower than the estimates
between subsequent epidemic peaks. This suggests an increase in
the number of NoV GII.4 infections, which is further reinforced
by a recent study of archival stool samples from the Children’s
Hospital, Washington, DC (1974 to 1991) (Bok et al., 2009).
Although this study identified GII.4 strains in the early seventies,
this was not the predominant genotype before 1991 (Bok et al.,
2009). An increase of the GII.4 variant therefore seems to provide
a plausible explanation for the coincident increase in the number
of norovirus infections.
Recently circulating GII.4 strains share a most recent
common ancestor in the early 1980s
The estimated substitution rates (961023substitutions per site
per year for the partial polymerase sequences and 5.361023
substitutions per site per year for the capsid sequences)
Figure 6. Predicted secondary structures in the 59end of the ORF2 GII.4 RNA, with all possible nucleotides modeled at site 26
(boxed). Four nucleotides upstream of the first ATG were included, as these are conserved in the 59end of ORF1 and ORF2 and likely to have a
function in translation.
doi:10.1371/journal.ppat.1000884.g006
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corresponded to the values recently reported for NoV GII.4 [40]
and were well within the range of what is commonly found for
RNA viruses, e.g. between 3.561023 and 8.561024 for HMPV
complete genomes [50] and for influenza A virus the highest rate,
reported for the HA gene, was 5.7261023 substitutions per site
per year [46]. A lower rate was observed for the polymerase subset
matched to the capsid data set. Since the TMRCA estimates were
consistent between these two polymerase data sets, the lower rate
may be explained by differences in rate variation among sites, in
particular for the proportion of invariant sites, which is sensitive to
the number of taxa in the data set [51]. Dating the MRCA for
these strains back to the early 1980’s does not mean that the GII.4
lineage arose only then, but rather suggests that the strains that
circulated during the past two decades share a common ancestor
at that time. It seems not unlikely that the GII.4 lineage was less
diverse before the 1980’s, not comprising different variants as
during the past decades. Alternatively, if multiple GII.4 variants
did exist before the MRCA of the current GII.4 variants, the
occurrence of a population bottleneck may have left progeny virus
of only one variant. The strains detected in the 1970s reported
recently seem to confirm that multiple GII.4 variants existed
before the Camberwell cluster arose [40]. Analyzing data of
multiple NoV genotypes will provide a more detailed insight into
the branching times of these different genotype clusters, and also in
this case, including older sequences will be more elucidating.
Possible shortcomings of this study
Ideally we would have used full genome sequences. However,
for (GII.4) NoV these are only sparsely available. Instead, we
showed that Bayesian coalescent demographic analyses of a large
dataset containing very short sequences offered important and
reliable insights into GII.4 variant dynamics. For the GII.4 NoV
datasets presented here, the densely sampled but short polymerase
sequences provided data that better defined the epidemic history
than fewer longer capsid sequences. Perhaps additional to the
limited size of the capsid dataset, strong selective pressure on the
capsid protein confounded analysis of the capsid gene. We were
also aware of the possibility that our capsid sequences dataset may
have been biased in sampling. Sequencing of full capsid genes is
not standard practice; the viruses of which sequences were
available have all previously been selected by various researchers
as ‘interesting enough to sequence’. Thus, relatively many
sequences of strains belonging to the 1996 variant are present in
the dataset, especially compared to strains belonging to the
younger variants, 2004, 2006a and 2006b.
Selective pressure shaped the population dynamics of
NoV GII.4 variants
Our genealogical test clearly rejected neutral evolution for the
NoV capsid dataset. Although P-values were somewhat higher
using a Bayesian skyline plot model in the posterior predictive
simulation compared to more restricted demographic functions,
we arrived at the same conclusions for all analyses. This
demonstrates that the neutrality test is not overly sensitive to the
demographic detail in the analysis. Nevertheless, through the
advances made here, we demonstrate that this test can now be
performed under any complex demographic scenario, a general-
ization that may further promote its use. To investigate the
selective forces in more detail, we fitted different evolutionary
models to identify sites in the capsid under selective pressure. We
examined an extension of previously performed dN/dS analyses
[23,40] to detect positively selected sites involved in population
level selection, avoiding the effect of within host evolution. Eight
positively selected codons were identified at p,0.05 with the iFEL
approach. Of these sites, four (352, 372, 395 and 407) are located
in the protruding regions of the protein. These sites have also been
identified previously as ‘informative’ sites (at least two shared an
identical amino acid mutation in the alignment) [20]. Amino acid
395, that was also detected as directionally evolving, is located in a
surface exposed loop of the capsid protein, that is part of a variable
site of carbohydrate interaction (amino acids 393-394-395) that
has been identified by a number of studies as a locus for ligand
binding and specificity [23,52,53]. Codon 394, located in this
same domain, is part of an intricate network of co-evolving
positions, also containing codons 297, 368 and 372. Amino acid
297 is part of a site identified by Allen et al, (296-297-298) [52],
predicted as another of two host ligand binding sites. This
particular site was not identified by Cao et al. [53] who performed
co-crystallization assays with P-particle dimers and A and B-
trisaccharides, the host ligands of NoV. It is structurally close to
amino acids 368 and 372, on top of the protein, flanking the ligand
binding pockets, and to 294, under directional evolution, which is
located on the outside of the 296–298 loop, relative to the binding
pocket.
Lindesmith et al. also identified sites under positive selection,
using fewer sequences. They used three different methods, single
likelihood ancestor counting (SLAC), fixed effects likelihood (FEL)
and random effects likelihood (REL), under the Tamura-Nei
model of evolution. More codons under positive selection were
identified in this study, but less strict nominal significance values
were used. Bok et al. [40] applied SLAC analyses for detection of
positive selection and found six amino acids under positive
selection. We chose to identify sites under selective pressure for
internal branches in a phylogeny using iFEL because external
branches are prone to deleterious mutational load. Such mutations
are expected to be young and more likely fall on the external
branches of a population-level phylogeny [54], where they can
confound the identification of positively selected sites. To avoid
this adverse effect we focused on internal branches only, on which
advantageous mutations are more likely to fall.
Codon 333 was previously identified as an informative site [20]
and our analyses found it to be under directional selection. It is
located in the hydrophobic part of the P-dimer interface, just
below the carbohydrate binding site described by Tan et al. [55],
facing its counterpart in the other protomer of the same dimer
(distance 4 A˚) [53]. Changes in this amino acid are not likely to be
involved in antigenic change but more likely structural compen-
sation for other mutations.
Positive selection is not only detected for sites involved
in immune escape; secondary RNA structures are
important for efficient RNA translation
Codons 6 and especially 9 have consistently been identified as
sites under strong selective pressure, and involved in defining the
distinction between variants, not only in this study but in others as
well [23,56]. Given their positions at the N-terminus of the
protein, inside the shell, they seemed unlikely to have been under
selective pressure through antibody recognition. This notion led us
to investigate the RNA encoding the 59end of ORF2. The
nucleotide sequence upstream of codon 9 (nucleotide 26) is
strongly conserved among all NoV genotypes, and a highly similar
sequence is found at the 59end of ORF1 in NoVs. Mutations have
rarely been detected here, apart from at nucleotide 26, and at
nucleotide 17 (codon 6). We propose that secondary structure
predictions of these RNA regions provide an explanation for this
pattern (Figure 5). Highly conserved stem-loop structures create
the circumstances necessary for translation initiation of ORF1 and
ORF2. Nucleotides A, C and G at position 26 all result in almost
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identical structures, in which 7 nucleotides from the start of ORF2,
or 11 when including the 4 nucleotides upstream from the AUG,
are left free. When theoretically a U/T is inserted here the
predicted structure changes, resulting in a diminished length of the
free nucleotide strand of 5 nucleotides. We are unaware of
sequences with nucleotide T at position 26 present either in our or
the public databases (data not shown), leading us to believe that a
length of at least 7 unpaired nucleotides counting from the first
AUG is necessary for efficient RNA translation from the
subgenomic RNA. Thus, while normal capsids could be formed
from strains with (silent) mutations in this area, the replication
process of the virus may be disrupted by altering the secondary
RNA structures. This theory is further supported by the
observation that no other synonymous or non-synonymous
mutations are found in the 9th codon, e.g. at the third nucleotide
position, nor at other nucleotides in this genomic area, apart from
the previously mentioned nucleotide 17, in an RNA loop.
Tentative analyses of other NoV genotypes demonstrated that
the 59 region is equally conserved within the different genotypes
and yielded similar secondary RNA structures, which allow for
point mutations in the loops of the structures (data not shown). To
further substantiate this hypothesis site-directed mutagenesis
studies are required, which go beyond the scope of this study.
Identifying future new GII.4 variants
All of the substitutions described above were associated with at
least one variant transition; they appear at branches that give rise
to new variants (Figure 5 and Figures S2, S3A and S3B). This
indicates that these mutations include the molecular determinants
of cluster replacement. Previously identified antigenic sites [23,52]
did not enable distinction between all the different GII.4 variants
(e.g. considering amino acids 296–298 and 393–395, the 2006b
and 2007 variants that are clearly phylogenetically distinct, share
identical amino acids).
When amino acids 6, 9, 294, 333, 352, 368, 372, 407 and 534,
identified here as under positive, directional or co-evolutionary
pressure, are added to these six amino acids, all currently identified
GII.4 variants (excluding the Bristol and Camberwell strains, that
circulated before the 1996 variant) are separated by at least two
amino acid differences (Figure S4). Thus, specific analysis of these
sites will aid early recognition of novel variants in the future. The
two most recent distinct GII.4 variants, that have both been
detected throughout the world in both 2008 and 2009, albeit at
low prevalence, the 2007- and 2008-variants, are identical to the
still dominant 2006b variant in amino acids 296–298, that were
identified by Allen et al, and 2007 is also identical in site 393–395,
whereas the 2008 variant has two substitutions on those sites
(2006b: STT, 2008: D/NTA). Thus, considering the sites listed
above, the 2008 variant would have the best chance of becoming
the next dominant strain, whereas, when considering the full
capsid sequence, the 2008 variant is more similar to the 2006b
variant than is the 2007 variant.
Using Bayesian phylodynamic techniques we showed that since
2002 the number of GII.4 infections has experienced expansion
dynamics. Additionally we further substantiated the evidence for
signature sites for variant transition, which may aid in the early
recognition of potential new epidemic variants, although we stress
that examining pre-defined amino acids does not enable certain
identification of GII.4 variants, for which full capsid sequences
should be determined. We showed that it is important to select the
genomic region to analyze by phylodynamic, coalescent methods
with care, and our different datasets illustrated that for the
phylodynamic analysis of pathogens undergoing repeated selective
bottlenecks a considerable sampling density through time is
required.
Materials and Methods
Datasets and data preparation
We compiled two different NoV GII.4 datasets. First, partial
polymerase gene sequences with known detection month and year
were collected. These sequences, encoding a short genomic region
commonly referred to as Region A, have been collected for
genotyping purposes, as an essential part of the ongoing
surveillance practice in institutions around the world [22,33].
This dataset includes sequences from participants of the
Foodborne Viruses in Europe (www.fbve.nl) and of the Noronet
(www.noronet.nl) networks, the contributing institutions of which
are listed in the acknowledgements. Sequences of sufficient length
(i.e. covering at least the final region) were included, generating a
dataset of 1383 taxa, 247 nt in length. Strains originated from
systematic surveillance collections, and form the best representa-
tive reflection of the circulating strains currently available.
Second, complete capsid sequences of GII.4 NoV strains with
known sampling date were collected. This resulted in a dataset of
194 taxa, 1623 nt long. To allow comparison of results from
capsid based versus polymerase based analysis, a set of 172 partial
polymerase gene sequences matching the sequences in the capsids
dataset (identical variant typing and similar detection dates) were
selected from the total polymerase dataset. The 2003Asia variant
was excluded from this mirror-dataset, since it was identified as
recombinant and ORF1 does not belong to the GII.4 genotype.
Details on the nature of the strains comprised by the two
generated datasets are provided in the Supporting Materials Table
S1. The distribution of the sampling dates of the included
sequences is depicted in Figure S5.
For recombination analyses, a set comprising 20 sequences, two
of each GII.4 variant, spanning the genome region between
Region A, in ORF1, and the complete capsid sequence was
collected.
Sequences were aligned using the Clustal W algorithm
implemented in Bioedit (version 7.0.9.0) and edited where
necessary. Sequence alignments can be obtained from the authors
on request.
Recombination analysis
Recombination within the genomic area under study invalidates
the use of phylogenetic approaches. Therefore, we checked for
possible recombination signal by analyzing 20 sequences (two for
each variant) spanning Region A through the complete capsid
protein (2404 nt). Different evolutionary histories across this
genome region were inferred using the genetic algorithm for
recombination detection (GARD) [57] and specific recombinants
were identified using a modified VisRD algorithm [58] and using
RDP3 [59]. In addition, we used the Phi test, shown to perform
well under strong population growth and to be able to distinguish
recurrent mutations from recombination events, to identify
recombination signal in the NoV alignments [36].
Time-measured phylodynamic analyses and associated
neutrality test
Evolutionary dynamics were estimated using a Bayesian
Markov chain Monte Carlo (MCMC) approach implemented in
BEAST (BEAST version 1.4.7 [60]). BEAST MCMC analysis
estimates marginal posterior distributions for every parameter in a
full probabilistic model comprising the timed evolutionary history,
based on the incorporation of sampling times in a molecular clock
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model, the substitution process and demographic history. We used
the GTR+I+C4 model of substitution and the uncorrelated
lognormal relaxed clock model to accommodate variation in
substitution rates among different branches [61].
To test selective neutrality of GII.4 molecular evolution, we
adopted the genealogical framework presented by Drummond and
Suchard [37]. This involves the full model-based Bayesian analysis
to obtain a posterior distribution of trees, genealogical summary
statistics, and posterior predictive simulation to detect departures
from the neutral expectations for these statistics. We employed the
genealogical Fu and Li statistic (DF), which compares the length of
terminal branches to the total length of the coalescent genealogy.
Strongly negative values for this statistic indicate terminal branch
lengths being larger than expected, which reflects an excess of
slightly deleterious mutations on these branches. This statistic has
proven to be most sensitive in uncovering non-neutral evolution,
and has for example rejected neutrality for human IAV
hemagglutinin genes [37]. Posterior predictive simulation is
performed according to the same demographic model as used in
to obtain the posterior tree distribution. To evaluate the impact of
large demographic trends, we compared analyses using both
constant and exponential growth population size priors. To further
investigate the impact of demographic detail on the neutrality test
we extended the simulation procedure to highly parametric
demographic models, including piecewise constant demographic
functions that define a Bayesian skyline plot model. We validated
the simulation procedure by comparing the reconstructed
Bayesian skyline plot from the trees generated by posterior
predictive simulation with the Bayesian skyline plot inferred from
the sequence data, which yielded consistent results.
To reconstruct the NoV GII.4 demographic history in more
detail, we employed the Bayesian skyline plot (BSP) model, which
generates piecewise constant population size trajectories [62]. In this
coalescent setting, demography is measured as the product of
effective population size (Ne) and generation time (t), Ne t, through
time. To obtain a detailed measurement of NoV GII.4 diversity
through time, given the large dataset, we specified 40 groups in the
piecewise constant population size function. All chains were run
sufficiently long to achieve stationarity after burn-in, as checked
using TRACER (http://tree.bio.ed.ac.uk/software/tracer/).
Additionally, the polymerase dataset was split up into separate
subsets, each comprising all available sequences from a major
GII.4 variant, and these were analyzed individually using the same
model and settings as was used for the whole polymerase dataset.
To examine how different sampling densities through time can
impact our demographic estimates, we performed an additional
analysis of a subset of the polymerase data, containing sequences
selected to best mirror the sequences in the capsid dataset, using
the same specifications as described above.
Analyses of molecular adaptation
Codon substitution analyses. Selective pressure in the capsid
genes was analyzed using the nonsynonymous/synonymous rate ratio
(dN/dS) in a codon model framework (reviewed in [63]). Probabilistic
models of codon substitution can be used to identify various types of
selection pressures in the evolutionary history of a gene. Diversifying
positive selection is characterized by dN/dS.1, which indicates that
(adaptive) nonsynonymous substitutions have accumulated faster
than synonymous substitutions. We considered a generalization of the
random effects Dual model [64], where synonymous and non-
synonymous rates are drawn from independent general discrete
distributions. In this study, we fitted a general bivariate discrete
distribution (GBDD) of substitution rates to the data using maximum
likelihood in HyPhy [41,65]. A GBDD on D rates estimates 3D-2
parameters: a pair of rates (synonymous and non-synonymous) and a
weight for each class. Two constraints that must be satisfied by the
parameters are: the weights must sum to one, and the mean for
synonymous rates must also be one to avoid confounding the mean of
substitution rates and the length of the tree (see [64] for details). This
distribution allows dN and dS to co-vary, by directly estimating the
values for dS and dN for D rate classes, instead of assuming that they
are selected independently. The value of D was determined by a step-
up procedure on D (starting with D= 1), where the fit of models with
D and D+1 rate classes was compared using small sample AIC.
Posterior distributions of substitution rate parameters were
approximated using sampling importance resampling. We
identified sites under diversifying or positive selection using an
empirical Bayes procedure. We chose an empirical Bayes Factor cut-
off of 20 to classify positively selected sites [64]. Additionally we
carried out a selection analysis using a random effects model (REL),
and a fixed effects likelihood (FEL) approach [66] to confirm the
predictions of the REL method and performed dataset-specific
simulations [67] on internal braches, as considering internal branches
is more relevant than the analysis of terminal branches in population
level selection [42], to estimate the operating characteristics of the
site-specific likelihood ratio test.
Directional evolution analyses. To detect directional
selection we used the DEPS test that identifies statistically
significant shifts in amino acid residue frequencies over the tree
and/or an unusually large number of substitutions towards a
particular residue in a maximum likelihood context [38]. DEPS
tests whether the amino acid substitution rate towards a particular
residue as estimated using a directionally biased model is
significantly different from baseline, reversible substitution rates.
For this procedure, we used the amino acid substitution rates
estimated under the general reversible protein model (REV) for
the baseline and directionally biased models and employed the
rooted maximum clade credibility from the BEAST analysis.
Epistatic effects, or co-evolutionary analyses of amino
acids. Co-evolving sites, showing evidence for concurrent
amino acid substitutions, were identified using Bayesian
graphical models (BGM) in a phylogenetic framework [68].
Briefly, this method infers the history of substitution events using
a codon-based maximum likelihood phylogenetic approach.
Correlated patterns of nonsynonymous substitutions are
subsequently identified using BGMs and an order-MCMC
algorithm. Two modes of analyses were performed allowing
either a single or two co-dependencies per site. We reported sites
identified with P.0.9 by either mode.
RNA secondary structure predictions
Secondary structure predictions of the 59end of the ORF2
encoding RNA were generated using the web based RNA Fold
Webserver (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) [69].
Supporting Information
Figure S1 Comparison of Bayesian Skyline Plots of the
polymerase dataset, the capsid dataset, and the dataset comprised
of partial polymerase sequences matching the sequences in the
capsid dataset.
Found at: doi:10.1371/journal.ppat.1000884.s001 (0.25 MB
TIF)
Figure S2 Sites identified to be under directional selection by
DEPS analysis. Sites are depicted by MCC trees colored for which
amino acid was present on each branch.
Found at: doi:10.1371/journal.ppat.1000884.s002 (0.25 MB
TIF)
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Figures S3 Co-evolving sites. S3A) Sites 238 and 504. S3B) Sites
231 and 509.
Found at: doi:10.1371/journal.ppat.1000884.s003 (0.28 MB
TIF)
Figure S4 Minimum Spanning Tree (MST) of amino acids 6, 9,
294, 296-297-298, 333, 352, 368, 372, 393-394-395, 407, 534.
Thick lines represent distances of 1 or 2 amino acids, thin lines 3
or more. An MST connects all samples in such a manner that the
summed distance between all samples or branches is minimized.
Different colors indicate the different variants. Different variants
are separated by at least 2 amino acids.
Found at: doi:10.1371/journal.ppat.1000884.s004 (0.52 MB
TIF)
Figures S5 Detection dates of NoV GII.4 strains included in the
study. S5A) The polymerase sequence detection dates. S5B) The
capsid sequence detection dates.
Found at: doi:10.1371/journal.ppat.1000884.s005 (0.18 MB
TIF)
Table S1 Background information on strains comprised by the
two datasets. NA: Not Assigned, C’well: Camberwell.
Found at: doi:10.1371/journal.ppat.1000884.s006 (0.09 MB
DOCX)
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